T-type calcium channels in the regulation of afferent and efferent arterioles in rats

被引:47
|
作者
Feng, MG
Li, M
Navar, LG
机构
[1] Tulane Univ, Sch Med, Dept Physiol, Hypertens & Renal Ctr Excellence, New Orleans, LA 70112 USA
[2] Tulane Univ, Sch Med, Dept Pharmacol, Hypertens & Renal Ctr Excellence, New Orleans, LA 70112 USA
关键词
diltiazem; pimozide; mibefradil; kidney; renal autoregulation;
D O I
10.1152/ajprenal.00251.2003
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
L-type Ca2+ channels predominantly influence preglomerular arterioles, but there is less information regarding the role of T-type Ca2+ channels in regulating the renal microvasculature. We compared the effects of T- and L-type channel blockade on afferent and efferent arterioles using the in vitro blood-perfused juxtamedullary nephron preparation. Single afferent or efferent arterioles of Sprague-Dawley rats were visualized and superfused with solutions containing Ca2+ channel blockers. We confirmed that L-type channel blockade with diltiazem dilates afferent arterioles but has no significant effects on efferent arterioles. In contrast, T-type channel blockade with pimozide (10 mumol/l) or mibefradil (1 mumol/l) dilated both afferent (26.8+/-3.4 and 24.6+/-1.9%) and efferent (19.2+/-2.9 and 19.1+/-4.8%) arterioles. Adding diltiazem did not significantly augment the dilation of afferent arterioles elicited by pimozide and mibefradil, and adding pimozide after diltiazem likewise did not elicit further vasodilation. Diltiazem blocked the depolarization-induced afferent arteriolar constriction elicited by 55 mM KCl; however, the constrictor response to KCl remained intact during treatment with 10 muM pimozide. Pimozide also prevented the afferent arterioles from exhibiting autoregulatory-mediated constrictor responses to increases in perfusion pressure. We conclude that T-type channel blockers dilate efferent arterioles as well as afferent arterioles and diminish afferent arteriolar autoregulatory responses to changes in perfusion pressure. To the extent that these agents exert their effects primarily on T-type Ca2+ channels in our experimental setting, these results indicate that T-type channels are functionally expressed in juxtamedullary afferent and efferent arterioles and may act cooperatively with L-type channels to regulate afferent arteriolar resistance. Because L-type channels are not functionally expressed in efferent arterioles, T-type channels may be particularly significant in the regulation of efferent arteriolar function.
引用
收藏
页码:F331 / F337
页数:7
相关论文
共 50 条
  • [1] Angiotensin II-mediated constriction of afferent and efferent arterioles involves T-type Ca2+ channel activation
    Feng, MG
    Navar, LG
    AMERICAN JOURNAL OF NEPHROLOGY, 2004, 24 (06) : 641 - 648
  • [2] Nitric oxide synthase inhibition activates L- and T- type Ca2+ channels in afferent and efferent arterioles
    Feng, MG
    Navar, LG
    AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2006, 290 (04) : F873 - F879
  • [3] T-Type Calcium Channels: A Mixed Blessing
    Melgari, Dario
    Frosio, Anthony
    Calamaio, Serena
    Marzi, Gaia A.
    Pappone, Carlo
    Rivolta, Ilaria
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (17)
  • [4] The Role of L- and T-Type Calcium Channels in Local and Remote Calcium Responses in Rat Mesenteric Terminal Arterioles
    Braunstein, Thomas Hartig
    Inoue, Ryuji
    Cribbs, Leanne
    Oike, Masahiro
    Ito, Yushi
    Holstein-Rathlou, Niels-Henrik
    Jensen, Lars Jorn
    JOURNAL OF VASCULAR RESEARCH, 2009, 46 (02) : 138 - 151
  • [5] Neuroprotective effects of blockers for T-type calcium channels
    Wildburger, Norelle C.
    Lin-Ye, Avary
    Baird, Michelle A.
    Lei, Debin
    Bao, Jianxin
    MOLECULAR NEURODEGENERATION, 2009, 4
  • [6] Neuroprotective effects of blockers for T-type calcium channels
    Norelle C Wildburger
    Avary Lin-Ye
    Michelle A Baird
    Debin Lei
    Jianxin Bao
    Molecular Neurodegeneration, 4
  • [7] T-type calcium channels inhibitors: a patent review
    Giordanetto, Fabrizio
    Knerr, Laurent
    Wallberg, Andreas
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2011, 21 (01) : 85 - 101
  • [8] Pharmacology and Drug Discovery for T-Type Calcium Channels
    McGivern, Joseph G.
    CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2006, 5 (06) : 587 - 603
  • [9] Physiologic and pathophysiologic relevance of T-type calcium-ion channels: Potential indications for T-type calcium antagonists
    Hermsmeyer, K
    Mishra, S
    Miyagawa, K
    Minshall, R
    CLINICAL THERAPEUTICS, 1997, 19 : 18 - 26
  • [10] Cardiovascular T-type calcium channels: physiological and pharmacological significance
    Triggle, DJ
    JOURNAL OF HYPERTENSION, 1997, 15 : S9 - S15